- This topic has 3 replies, 4 voices, and was last updated 8 years, 3 months ago by
.
-
Posts
-
http://www.redhillbio.com/RedHill/userdata/SendFile.asp?DBID=1&LNGID=1&GID=901
RedHill Biopharma Announces Completion of Dosing in
Phase IIa Study of RHB-104 for Multiple Sclerosis
About RHB-104:
Currently in a first Phase III study for the treatment of Crohn’s disease (the MAP US study)
and a second Phase III study which is being prepared (the MAP EU study), RHB-104 is a
proprietary and potentially groundbreaking antibiotic combination therapy in oral capsule
formulation, with potent intracellular, anti-mycobacterial and anti-inflammatory properties.
RHB-104 is based on increasing evidence supporting the hypothesis that Crohn’s disease is
caused by Mycobacterium avium subspecies paratuberculosis (MAP) infection in susceptible
patients.Mom of teen daughter with Poly JIA since age 2. Current med: azithromycin 250 mg MWF.
Suzanne!!! This is huge! They are already running the clinical trial for Crohn’s all over the country. Now they have made the connection that MS may have an infectious cause too. Yes, we already know about Stratton and Wheldon’s brilliant ap work for MS but when big pharma takes note – sad but true it takes big pharma to change how mainstream thinks- but when pharma takes note and funds the studies maybe the ride will finally turn for the cure!
What’s interesting is that redhill has combined three antibiotics into one pill
and they believe it can cure Crohn’s and possibly MS.
“RHB-104 is a triple antibiotic formula that is used to treat MAP bacterium. MAP is a shorter way of saying “Mycobacterium avium subspecies paratuberculosis” bacterium. The inception of RHB-104 dates back to the late 1990s with development being started by Dr. Thomas Borody of the Centre for Digestive Diseases. The three components of RHB-104 are Rifabutin, Clarithromycin and Clofazimine which are all rather common antibiotics, the difference is in using all three, dosage level & duration of treatment.”Dr. H.z is working with Dr. Z. at Johns Hopkins. I know Maz has something ready to post on this!
“Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline”
Finally mainstream is making the connection!
“RHB-104 is a triple antibiotic formula that is used to treat MAP bacterium. MAP is a shorter way of saying “Mycobacterium avium subspecies paratuberculosis” bacterium. The inception of RHB-104 dates back to the late 1990s with development being started by Dr. Thomas Borody of the Centre for Digestive Diseases. The three components of RHB-104 are Rifabutin, Clarithromycin and Clofazimine which are all rather common antibiotics, the difference is in using all three, dosage level & duration of treatment.”
I recently met a patient of Dr Thomas Borody in Sydney (he’s the Sydney specialist who “invented” fecal transplants and who is regarded as a maverick by many conventional medicos and a god by his patients). He had such bad Crohns that he was down to 110 pounds and was fading fast. Brody treated him with a fecal transplant and abx (I think with this triple combo). He now has no sign of Crohns and is back up to normal weight for a 40 year old male and is able to eat normally.
Be well! Lynnie
Palindromic RA 30 yrs (Chronic Lyme?)
Mino 2003-2008 100mg MWF - can no longer tolerate any tetracyclines
rotating abx protocol now. From Sep 2018 MWF - a.m. Augmentin Duo 440mg + 150mg Biaxsig (roxithromycin). p.m. Cefaclor (375mg) + Klacid 125mg + LDN 3mg + Annual Clindy IV's
Diet: no gluten, dairy, sulphites, low salicylates
Supps: 600mg N-AC BID, 1000mg Vit C, P5P 40mg, zinc picolinate 60mg, Lithium orotate 20mg, Magnesium Oil, Bio-identical hormones (DHEA + Prog + Estrog)
You must be logged in to reply to this topic.